OUTLOOK THERAPEUTICS Trademark

Trademark Overview

On Monday, June 27, 2022, a trademark application was filed for OUTLOOK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OUTLOOK THERAPEUTICS trademark a serial number of 97478024. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, December 23, 2024. This trademark is owned by Outlook Therapeutics, Inc.. The OUTLOOK THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
outlook therapeutics

General Information

Serial Number97478024
Word MarkOUTLOOK THERAPEUTICS
Filing DateMonday, June 27, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, December 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and ServicesPharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOutlook Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830
Party NameOutlook Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIselin, NJ 08830

Trademark Events

Event DateEvent Description
Thursday, June 30, 2022NEW APPLICATION ENTERED
Thursday, July 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 10, 2023ASSIGNED TO EXAMINER
Wednesday, April 12, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 12, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, April 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 12, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, April 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 1 FILED
Tuesday, January 9, 2024SOU EXTENSION 1 GRANTED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 28, 2024SOU EXTENSION 2 FILED
Friday, June 28, 2024SOU EXTENSION 2 GRANTED
Monday, December 23, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 23, 2024SOU EXTENSION 3 FILED
Friday, June 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 24, 2024SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 19, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

therapeutics outlook retinal disease treatment drugs namely ophthalmic pharmaceuticals